← back to database
NYBC Ventures is a venture capital fund established by New York Blood Center Enterprises (NYBCe) with a $50 million commitment. It focuses on accelerating innovation in blood and cellular therapies, supporting therapeutics, devices, and other breakthrough solutions. The fund leverages NYBC's expertise in these areas to drive investment performance and improve patient lives. Their investment strategy targets early to mid-stage innovations in hematology, transfusion medicine, cell therapy, and infectious disease.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Christopher D. HillyerGeneral Partner, Manager
- Jay MohrGeneral Partner, Manager
- Meg WoodManaging Director
- Kuan YuSenior Analyst